CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on targeting the nerve growth factor receptor p75NTR in melanoma cells and their extracellular vesicles to inhibit melanoma progression and metastasis. By employing phage display techniques, it aims to identify specific peptide ligands that could lead to new therapeutic strategies for treating this…
Melanoma, the deadliest form of skin cancer, is strongly influenced by environmental factors such as UV radiation from ozone depletion.
In 2022, there were 331,722 new melanoma cases globally, and by 2040, cases are expected to rise by 50%. A major challenge in treating melanoma is its ability to metastasize, especially when therapeutic targets are unclear or when tumors develop resistance to existing treatments.
Recent research findings have identified the nerve growth factor receptor p75NTR as…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
